StockNews.com Downgrades LivaNova (NASDAQ:LIVN) to Buy

LivaNova (NASDAQ:LIVN) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Saturday.

Other analysts have also recently issued reports about the company. Needham & Company LLC reissued a “buy” rating and set a $75.00 target price on shares of LivaNova in a research note on Tuesday, November 12th. Baird R W raised shares of LivaNova from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, September 17th. Stifel Nicolaus boosted their price objective on shares of LivaNova from $70.00 to $72.00 and gave the company a “buy” rating in a research report on Thursday, July 25th. Mizuho reduced their target price on shares of LivaNova from $80.00 to $70.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Finally, The Goldman Sachs Group initiated coverage on LivaNova in a research note on Friday, October 4th. They issued a “buy” rating and a $65.00 price target on the stock. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, LivaNova presently has an average rating of “Buy” and an average price target of $69.17.

LivaNova Stock Down 0.4 %

Shares of LivaNova stock opened at $52.10 on Friday. The company has a market capitalization of $2.83 billion, a P/E ratio of 124.05 and a beta of 1.01. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.37 and a quick ratio of 2.87. The business has a 50-day moving average of $51.77 and a two-hundred day moving average of $52.93. LivaNova has a 1 year low of $42.75 and a 1 year high of $64.47.

Hedge Funds Weigh In On LivaNova

A number of large investors have recently modified their holdings of LIVN. Fifth Third Bancorp boosted its holdings in shares of LivaNova by 97.1% in the 2nd quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock valued at $37,000 after buying an additional 332 shares during the last quarter. Hexagon Capital Partners LLC raised its position in LivaNova by 117.8% during the second quarter. Hexagon Capital Partners LLC now owns 684 shares of the company’s stock worth $37,000 after acquiring an additional 370 shares in the last quarter. Lazard Asset Management LLC acquired a new stake in LivaNova in the first quarter valued at $84,000. Canada Pension Plan Investment Board bought a new position in shares of LivaNova in the 2nd quarter valued at about $88,000. Finally, Acadian Asset Management LLC acquired a new position in shares of LivaNova during the 1st quarter worth about $94,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.